Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
Conditions
Bladder Squamous Cell Carcinoma · Locally Advanced Bladder Carcinoma · Malignant Renal Pelvis Neoplasm · Malignant Ureter Neoplasm · Malignant Urethral Neoplasm · Metastatic Bladder Carcinoma · Stage III Bladder Cancer AJCC v8 · Stage IV Bladder Cancer AJCC v8 · Unresectable Bladder Carcinoma · Urachal Adenocarcinoma · Bladder Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Grady Health System, Atlanta, Georgia, United States
Contact: Principal Investigator (Jacqueline Brown, MD)Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Jacqueline Brown, MD)Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Jacqueline Brown, MD)Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jacqueline Brown, MD)
Study leads
Jacqueline Brown, MD
Principal Investigator
Emory University Hospital/Winship Cancer Institute